- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Quinsam Outlines Investment Plan with Osoyoos Cannabis
Quinsam Capital announced it reached an agreement to invest in Osoyoos Cannabis.
Quinsam Capital (CSE:QCA) announced it reached an agreement to invest in Osoyoos Cannabis.
As quoted in the press release:
The planned $262,500 investment in Osoyoos will include a 3-year 10% convertible debenture as well as warrants. Quinsam will also obtain an arrangement fee payable in shares of Osoyoos. Closing of the investment is expected in the near term. Quinsam expects Osoyoos to seek a stock exchange listing in the coming months.
“While Osoyoos is not as advanced as some other ACMPR applicants, the valuation at which our investment has been made is reflective of that fact. We think that the Osoyoos team together with the relationship with the OIB and the advantages inherent in being an Aboriginal Applicant will allow Osoyoos to be successful” said Roger Dent.
Click here to read the full press release.
Source: globenewswire.com
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.